GlassScriptPhysician profile
Tamar Rubin
NPI 1679831267
$8,922.93
in general payments reported to CMS, 2019-2025
34 companies · $1,891 in 2025
The $1,891 reported for 2025 was more than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $519 · 2021: $1,016 · 2022: $1,410 · 2023: $2,127 · 2024: $1,363 · 2025: $1,891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,379.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,730.47 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $1,598.37 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $1,027.96 | 2020-2025 | Hyqvia, Takhzyro, Cuvitru |
| Regeneron Healthcare Solutions, INC. | $897.63 | 2021-2025 | Dupixent |
| Optinose US, INC. | $629.57 | 2019-2025 | |
| Pfizer INC. | $434.47 | 2019-2024 | |
| Blueprint Medicines Corporation | $312.23 | 2023 | Ayvakit |
| Alk-Abello, INC | $295.99 | 2019-2024 | Grastek, Odactra, Ragwitek |
| Csl Behring | $238.72 | 2021-2023 | Haegarda |
| Novartis Pharmaceuticals Corporation | $201.17 | 2019-2025 | |
| Biocryst US Sales Co., LLC | $192.11 | 2022-2024 | Orladeyo |
| Ars Pharmaceuticals Operations, INC. | $159.27 | 2025 | Neffy |
| Amgen INC. | $146.75 | 2021-2023 | Tezspire |
| Genentech, INC. | $139.49 | 2025 | Xolair |
| Genzyme Corporation | $128.19 | 2019-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $126.60 | 2022 | |
| Genentech USA, INC. | $123.27 | 2019-2025 | Xolair |
| Kaleo, INC. | $82.12 | 2021-2024 | Auvi-Q |
| Aimmune Therapeutics, INC. | $62.91 | 2020-2022 | |
| Pharming Healthcare, INC. | $61.71 | 2022-2025 | Ruconest |
| Covis Pharma Gmbh | $44.03 | 2023 | |
| Grifols USA, LLC | $41.12 | 2024-2025 | Prolastin-C Liquid, Xembify |
| Paratek Pharmaceuticals, INC. | $33.51 | 2025 | Xhance |
| Leo Pharma INC. | $31.71 | 2024 | Adbry |
| Ionis Pharmaceuticals, INC. | $30.85 | 2025 | Dawnzera |
| Azurity Pharmaceuticals, INC. | $26.79 | 2025 | Alvesco |
| Mylan Specialty L.P. | $21.41 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $20.67 | 2020 | |
| Shire North American Group INC | $20.31 | 2019 | |
| Lilly USA, LLC | $17.27 | 2025 | Ebglyss |
| Kedrion Biopharma, INC. | $16.29 | 2025 | Albuked, Rhogam Ultra-Filtered Plus, Kedrab |
| Bio Products Laboratory USA, INC. | $14.39 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.17 | 2019 | |
| Organon LLC | $4.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamar Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.